Post-radiotherapy maintenance treatment with fluticasone propionate and salmeterol for lung cancer patients with grade III radiation pneumonitis: A case report

RATIONALE: This combination of fluticasone propionate (FP) and the long-acting β2-agonist salmeterol (Salm) can control the symptoms of asthma and COPD better than FP or Salm on their own and better than the combination of inhaled corticosteroids plus montelukast. FP/Salm has been shown to control s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Pingping, Yan, Hongxia, Wang, Sheng, Kai, Jindan, Pi, Guoliang, Peng, Yi, Liu, Xiyou, Sun, Junwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392590/
https://www.ncbi.nlm.nih.gov/pubmed/29794744
http://dx.doi.org/10.1097/MD.0000000000010681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392590/
https://www.ncbi.nlm.nih.gov/pubmed/29794744
http://dx.doi.org/10.1097/MD.0000000000010681

Ejemplares similares